Document:

Exhibit 10.1

 

EXECUTION
VERSION

 

PURCHASE AGREEMENT

 

United States Steel Corporation

 

$1,056,357,000 12.000% Senior Secured
Notes due 2025

 

May 21, 2020

 

J.P. Morgan Securities LLC

 

As Representative of the

several Initial Purchasers listed

in Schedule 1 hereto

 

c/o J.P. Morgan Securities
LLC

383 Madison Avenue

New York, New York 10179

 

Ladies and Gentlemen:

 

United States Steel
Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed
in Schedule 1 hereto (the “Initial Purchasers”), for whom J.P. Morgan Securities LLC is acting as representative (the
 “Representative”), $1,056,357,000 aggregate principal amount of its 12.000% Senior Secured Notes due 2025 (the “Securities”).
The Securities will be issued pursuant to an indenture to be dated as of May 29, 2020 (the “Indenture”), among
the Company, the guarantors listed in Schedule 2 hereto (collectively, the “Guarantors”) and U.S. Bank, National Association,
as trustee (in such capacity, the “Trustee”) and as collateral agent (in such capacity, the “Collateral Agent”),
and will be guaranteed on a senior secured basis by the Guarantors (the “Guarantees”).

 

The Company and the
Guarantors hereby confirm their agreement with the several Initial Purchasers concerning the purchase and sale of the Securities,
as follows:

 

1.            Offering
Memorandum and Transaction Information. The Securities will be sold to the Initial Purchasers without being registered under
the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon an exemption therefrom. The Company
and the Guarantors have prepared drafts of the preliminary offering memorandum dated May 18, 2020 and May 20, 2020 (together,
the “Preliminary Drafts”) and a preliminary offering memorandum dated May 20, 2020 (the “Preliminary Offering
Memorandum”) and will prepare an offering memorandum dated the date hereof (the “Offering Memorandum”) setting
forth information concerning the Company, the Guarantors and the Securities. Copies of each of the Preliminary Drafts and the Preliminary
Offering Memorandum have been, and copies of the Offering Memorandum will be, delivered by the Company to the Initial Purchasers
pursuant to the terms of this purchase agreement (this “Agreement”). The Company hereby confirms that it has authorized
the use of the Preliminary 

 

     

     

    

 

Offering Memorandum, the other Time of Sale Information (as defined below) and the Offering Memorandum
in connection with the offering and resale of the Securities by the Initial Purchasers in the manner contemplated by this Agreement.
References herein to the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum shall be deemed
to refer to and include any document incorporated by reference therein and any reference to “amend,” “amendment”
or “supplement” with respect to the Preliminary Offering Memorandum or the Offering Memorandum shall be deemed to refer
to and include any documents filed after such date and incorporated by reference therein. Capitalized terms used but not defined
herein shall have the meanings given to such terms in the Preliminary Offering Memorandum.

 

At or prior to 4:00
p.m. on May 21, 2020, the time when the first sale of the Securities was made (the “Time of Sale”), the Company
had prepared the following information (collectively, the “Time of Sale Information”): the Preliminary Offering Memorandum,
as supplemented and amended by the written communications listed on Annex A hereto.

 

The Securities and
the Guarantees will be secured by a first-priority lien, subject to Permitted Liens (as defined below), on substantially all of
the tangible and intangible assets of the Company and the Guarantors, now owned or hereafter acquired by the Company and any Guarantors
(other than ABL Collateral (as defined in the Time of Sale Information), real property owned by the Company or any Guarantor as
of the Closing Date that is not listed on Schedule 4 hereto and certain other excluded assets), as described in the Indenture and
the Collateral Documents (as defined below) (the “Collateral”). The Collateral shall be described in: (a) with
respect to real property listed on Schedule 4 hereto, to be delivered in accordance with Schedule 5 hereto, the mortgages, deeds
of trust or deeds to secure debt (collectively, the “Mortgages”), (b) with respect to personal property that constitutes
Collateral, the Collateral Agreement (the “Collateral Agreement”), to be dated as of the Closing Date (as defined below),
and entered into by the Company, the Guarantors and the Collateral Agent and (c) with respect to the grants of security interests
in registrations and/or applications for trademarks, patents and copyrights (and exclusive licenses in any of the foregoing), in
either the Collateral Agreement or, respectively, in the Trademark Security Agreement, the Patent Security Agreement and the Copyright
Security Agreement, each to be dated as of the Closing Date and entered into by each of the Company and the Guarantors, as provided
therein (the “Trademark Security Agreement,” “Patent Security Agreement” and “Copyright Security
Agreement,” respectively, and, collectively, the “Intellectual Property Security Agreements”), each to be delivered
to the Collateral Agent, granting a first-priority security interest in the Collateral, subject to Permitted Liens, for the benefit
of the Trustee and each holder of the Securities and the successors and assigns of the foregoing. The term “Collateral Documents,”
as used herein, shall mean the Mortgages, the Collateral Agreement and the Intellectual Property Security Agreements. The rights
of the holders of the Securities with respect to the Collateral shall be further governed by the Collateral Cooperation Agreement
to be dated as of the Closing Date (the “Collateral Cooperation Agreement”), among the Company, certain of its subsidiaries,
the Collateral Agent and the agent for the lenders under the Fifth Amended and Restated Credit Agreement, dated as of October 25,
2019, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent
(as further amended, modified, supplemented, restated or amended and restated from time to time, the “Credit Agreement”).

 

    2

     

    

 

2.            Purchase
and Sale of the Securities. (a)  The Company agrees to issue and sell the Securities to the several Initial Purchasers
as provided in this Agreement, and each Initial Purchaser, on the basis of the representations, warranties and agreements set forth
herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the Company the respective
principal amount of the Securities set forth opposite such Initial Purchaser’s name in Schedule 1 hereto at a price equal
to 93.165% of the principal amount thereof plus accrued interest, if any, from May 29, 2020, to the Closing Date. The Company
will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein.

 

(b)         The
Company understands that the Initial Purchasers intend to offer the Securities for resale on the terms set forth herein and in
the Time of Sale Information. Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that:

 

(i)            it
is a qualified institutional buyer (“QIB”) within the meaning of Rule 144A under the Securities Act (“Rule 144A”)
and an accredited investor within the meaning of Rule 501(a)  of Regulation D under the Securities Act (“Regulation
D”);

 

(ii)           it
has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities by means of
any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner
involving a public offering within the meaning of Section 4(a)(2) of the Securities Act; and

 

(iii)          it
has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities as part of
the initial offering except:

 

(A)           within
the United States to persons whom it reasonably believes to be QIBs in transactions pursuant to Rule 144A and in connection
with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the Securities is aware that such
sale is being made in reliance on Rule 144A; or

 

(B)            in
accordance with the restrictions set forth in Annex C hereto.

 

(c)          Each
Initial Purchaser acknowledges and agrees that the Company and, for purposes of the “no registration” opinions to be
delivered to the Initial Purchasers pursuant to Sections 6(g) and 6(h), counsel for the Company and counsel for the Initial
Purchasers, respectively, may rely upon the accuracy of the representations and warranties of the Initial Purchasers, and compliance
by the Initial Purchasers with their agreements, contained in paragraph (b) above (including Annex C hereto), and each Initial
Purchaser hereby consents to such reliance.

 

(d)         The
Company and the Guarantors acknowledge and agree that the Initial Purchasers may offer and sell Securities to or through any affiliate
of an Initial Purchaser and that any such affiliate may offer and sell Securities purchased by it to or through any Initial Purchaser.

 

(e)          Payment
for and delivery of the Securities will be made at the offices of Simpson Thacher & Bartlett LLP at 10:00 a.m., New York
City time, on May 29, 2020, or at such other time or place on the same or such other date, not later than the fifth business
day thereafter, as the 

 

    3

     

    

 

Representative and the Company may agree upon in writing. The time and date of such payment and delivery
is referred to herein as the “Closing Date”.

 

(f)           Payment
for the Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Company
to the Representative against delivery to the nominee of The Depository Trust Company (“DTC”), for the account of the
Initial Purchasers, of one or more global notes representing the Securities (the “Global Notes”), with any transfer
taxes payable in connection with the sale of the Securities duly paid by the Company. The Global Notes will be in form and substance
reasonably satisfactory to the Representative.

 

(g)          The
Company and the Guarantors acknowledge and agree that the Initial Purchasers are acting solely in the capacity of an arm’s
length contractual counterparty to the Company and the Guarantors with respect to the offering of the Securities contemplated hereby
(including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent
of, the Company, the Guarantors or any other person with respect to such offering. Additionally, neither the Representative nor
any other Initial Purchaser is advising the Company, the Guarantors or any other person as to any legal, tax, investment, accounting
or regulatory matters in any jurisdiction. The Company and the Guarantors shall consult with their own advisors concerning such
matters and shall be responsible for making their own independent investigation and appraisal of the transactions contemplated
hereby, and neither the Representative nor any other Initial Purchaser shall have any responsibility or liability to the Company
or the Guarantors with respect thereto. Any review by the Representative or any Initial Purchaser of the Company, the Guarantors
and the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit
of the Representative or such Initial Purchaser, as the case may be, and shall not be on behalf of the Company, the Guarantors
or any other person.

 

3.           Representations
and Warranties of the Company and the Guarantors. The Company and the Guarantors jointly and severally represent and warrant
to each Initial Purchaser that:

 

(a)         Preliminary
Offering Memorandum. The Preliminary Offering Memorandum, as of its date, did not contain any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading; provided that the Company and the Guarantors makes no representation or warranty with
respect to any statements or omissions made in reliance upon and in conformity with information relating to any Initial Purchaser
furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in any Preliminary Offering
Memorandum, it being understood and agreed that the only such information furnished by any Initial Purchaser consists of the information
described as such in Section 7(b) hereof.

 

(b)         Time
of Sale Information. The Time of Sale Information, at the Time of Sale, did not, and at the Closing Date, will not, contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; provided that the Company and the Guarantors
make no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information
relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly
for use in 

 

    4

     

    

 

such Time of Sale Information, it being understood and agreed that the only such information furnished by any Initial
Purchaser consists of the information described in Section 7(b) hereof. No statement of material fact included in the
Offering Memorandum that is required to be included in the Time of Sale Information has been omitted from the Time of Sale Information
and no statement of material fact included in the Time of Sale Information that is required to be included in the Offering Memorandum
has been omitted therefrom.

 

(c)          Additional
Written Communications. The Company and the Guarantors (including their agents and representatives, other than the Initial
Purchasers in their capacity as such) have not prepared, made, used, authorized, approved or referred to and will not prepare,
make, use, authorize, approve or refer to any “written communication” (as defined in Rule 405 under the Securities
Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company
and the Guarantors or their agents and representatives (other than a communication referred to in clauses (ii), (iii) and
(iv) of this Section 3(c)), an “Issuer Written Communication”) other than (i) the Preliminary Drafts,
(ii) the Preliminary Offering Memorandum, (iii) the Offering Memorandum, (iv) the documents listed on Annex A hereto,
including a term sheet substantially in the form of Annex B hereto, which constitute part of the Time of Sale Information and (v) each
electronic road show and any other written communications approved in writing in advance by the Representative. Each such Issuer
Written Communication does not conflict with the information contained in the Time of Sale Information, and when taken together
with the Time of Sale Information (at the Time of Sale) accompanying, or delivered prior to delivery of, or filed prior to the
first use of such Issuer Written Communication, did not, and at the Closing Date will not, contain any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading; provided that the Company and the Guarantors make no representation or warranty with
respect to any statements or omissions made in each such Issuer Written Communication in reliance upon and in conformity with information
relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly
for use in any Issuer Written Communication, it being understood and agreed that the only such information furnished by any Initial
Purchaser consists of information described in Section 7(b) hereof.

 

(d)         Offering
Memorandum. As of the date of the Offering Memorandum and as of the Closing Date, the Offering Memorandum does not and will
not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; provided that neither the Company
or the Guarantors make any representation or warranty with respect to any statements or omissions made in reliance upon and in
conformity with information relating to any Initial Purchaser furnished to the Company and the Guarantors in writing by such Initial
Purchaser through the Representative expressly for use in the Offering Memorandum, it being understood and agreed that the only
such information furnished by any Initial Purchaser consists of the information described as such in Section 7(b) hereof.

 

(e)         Incorporated
Documents. The documents incorporated by reference in the Offering Memorandum or the Time of Sale Information, when filed with
the Commission, conformed or will conform, as the case may be, in all material respects with the requirements of the Securities
Exchange Act of 1934, as amended, and the rules and regulations of the Commission 

 

    5

     

    

 

thereunder (collectively, the “Exchange
Act”) and did not and will not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

(f)          Company
Organization and Good Standing. The Company has been duly incorporated and is an existing corporation in good standing under
the laws of the State of Delaware, with power and authority (corporate and other) to own its properties and conduct its business
as described in the Time of Sale Information and the Offering Memorandum; and the Company is duly qualified to do business as a
foreign corporation in good standing in all other jurisdictions in which its ownership or lease of property or the conduct of its
business requires such qualification, except where the failure to so qualify would not reasonably be expected to have a material
adverse effect upon the financial condition, business, properties or results of operations of the Company and its subsidiaries,
taken as a whole, or on the performance by the Company and the Guarantors of their respective obligations under this Agreement,
the Securities, the Guarantees and the Collateral Documents (a “Material Adverse Effect”).

 

(g)         Organization
and Good Standing of Guarantors and Designated Subsidiaries. The Guarantors and each subsidiary of the Company listed on Schedule
3 (each, a “Designated Subsidiary”) has been duly incorporated or otherwise organized and is an existing corporation,
limited liability company or other business entity in good standing (if such designation exists in the jurisdiction of organization
or formation of such entity) under the laws of the jurisdiction of its incorporation or organization, with power and authority
(corporate, limited liability company and other) to own its properties and conduct its business as described in the Time of Sale
Information and the Offering Memorandum; and the Guarantors and each Designated Subsidiary of the Company is duly qualified to
do business as a foreign corporation or other business entity in good standing in all other jurisdictions in which its ownership
or lease of property or the conduct of its business requires such qualification, except where the failure to so qualify would not
reasonably be expected to have a Material Adverse Effect; all of the issued and outstanding capital stock or other equity securities
of the Guarantors and each Designated Subsidiary of the Company have been duly authorized and are validly issued, fully paid and
nonassessable (except, in the case of any foreign subsidiary, for directors’ qualifying shares); and the shares of capital
stock or other equity securities of the Guarantors and each Designated Subsidiary owned by the Company, directly or through subsidiaries,
are owned free from any lien, charge, encumbrance, defect, security interest, restriction on voting or transfer or any other claim
of any third party (collectively, “Liens”), except such Liens that would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect. As of March 31, 2020, there are no significant subsidiaries of the Company
that are not listed on Schedule 3 hereto. The subsidiaries of the Company not listed on Schedule 3 hereto, in the aggregate, represented
no more than 15% of the (i) net sales of the Company and its subsidiaries for the twelve months ended March 31, 2020
and (ii) total assets of the Company and its subsidiaries as of March 31, 2020.

 

(h)         Capitalization.
All outstanding shares of capital stock of the Company have been duly authorized and are validly issued, fully paid and non-assessable
and are not subject to any pre-emptive or similar rights. The Company had an authorized capitalization as of March 31, 2020,
as set forth in each of the Time of Sale Information and the Offering Memorandum under the heading “Capitalization.”

 

    6

     

    

 

(i)           No
Broker’s Fees. Except as disclosed in the Time of Sale Information and the Offering Memorandum, there are no contracts,
agreements or understandings between the Company and any person that would give rise to a valid claim against the Company or any
Initial Purchaser for a brokerage commission, finder’s fee or other like payment in connection with this offering.

 

(j)          Due
Authorization. The Company and the Guarantors have full right, power and authority to execute and deliver this Agreement, the
Securities, the Indenture (including the Guarantees set forth therein), each of the Collateral Documents, to the extent a party
thereto, and the Collateral Cooperation Agreement, to the extent a party thereto (collectively, the “Transaction Documents”)
and to perform their respective obligations hereunder and thereunder, including granting the Liens and security interests to be
granted by it pursuant to the Indenture and the Collateral Documents.

 

(k)         No
Consents Required. No consent, approval, authorization, or order of, or filing with any governmental agency or body or, any
court is required for the execution, delivery and performance by the Company and the Guarantors of each of the Transaction Documents
to which each is a party (including, but not limited to, the filing of any applicable fixture filings relating to the real property
covered by the Mortgages, the filing of any applicable financing statements pursuant to the Collateral Agreement or the filing
of any Intellectual Property Security Agreements), the issuance and sale of the Securities and the issuance of the Guarantees,
the grant and perfection of liens and security interests in the Collateral pursuant to the Mortgages, the Collateral Agreement
and the Intellectual Property Security Agreements and compliance by the Company and the Guarantors with the terms thereof and the
consummation of the transactions contemplated by the Transaction Documents, except for such consents, approvals, authorizations,
orders and registrations or qualifications as may be required (i) under applicable state securities laws in connection with
the purchase and resale of the Securities by the Initial Purchasers, the failure of which to obtain or make would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect and (ii) to perfect the Trustee’s or the
Collateral Agent’s security interests granted pursuant to the Mortgages, the Collateral Agreement, the Intellectual Property
Security Agreements and the financing statements related thereto.

 

(l)          No
Conflicts. The execution, delivery and performance by the Company and the Guarantors of each of the Transaction Documents to
which each is a party (including, but not limited to, the filing of any applicable fixture filings relating to the real property
covered by the Mortgages, the filing of any applicable financing statements pursuant to the Collateral Agreement or the filing
of the Intellectual Property Security Agreements), the issuance and sale of the Securities and the issuance of the Guarantees,
the grant and perfection of liens and security interests in the Collateral pursuant to the Mortgages, the Collateral Agreement
and the Intellectual Property Security Agreements and compliance by the Company and the Guarantors with the terms thereof and the
consummation of the transactions contemplated by the Transaction Documents will not result in a breach or violation of any of the
terms and provisions of, or constitute a default under, (i) any statute, any rule, regulation or order of any governmental
agency or body or any court, domestic or foreign, having jurisdiction over the Company, the Guarantors or any Designated Subsidiary
of the Company or any of their properties, (ii) any agreement or instrument to which the Company, the Guarantors or any such
Designated Subsidiary is a party or by which the Company, the Guarantors or any such Designated Subsidiary is bound or to which
any of the

 

    7

     

    

 

 properties of the Company, the Guarantors or any such Designated Subsidiary is subject or (iii) the charter, by-laws
or other organizational document of the Company, the Guarantors or any such Designated Subsidiary.

 

(m)         The
Indenture.  The Indenture has been duly authorized by the Company and the Guarantors and on the Closing Date will be duly executed
and delivered by the Company and the Guarantors and, when duly executed and delivered in accordance with its terms by each of the
other parties thereto, will constitute a valid and legally binding agreement of the Company and the Guarantors enforceable against
the Company and the Guarantors in accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights
generally or by equitable principles relating to enforceability (whether considered in a proceeding at law or in equity collectively,
the “Enforceability Exceptions”).

 

(n)         The
Securities and the Guarantees. The Securities have been duly authorized by the Company and, when duly executed, authenticated,
issued and delivered in accordance with the Indenture and paid for as provided herein, will be duly and validly issued and outstanding
and will constitute valid and legally binding obligations of the Company enforceable against the Company in accordance with their
terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture; and the Guarantees has
been duly authorized by the Guarantors and, when the Securities have been duly executed, authenticated, issued and delivered as
provided in the Indenture and paid for as provided herein, will be valid and legally binding obligations of the Guarantors, enforceable
against the Guarantors in accordance with its terms, subject to the Enforceability Exceptions, and will be entitled to the benefits
of the Indenture.

 

(o)          Purchase
Agreement. This Agreement has been duly authorized, executed and delivered by the Company and the Guarantors.

 

(p)          Collateral
Documents and Collateral Cooperation Agreement. Each of the Collateral Documents and the Collateral Cooperation Agreement has
been duly authorized by the Company and the Guarantors, to the extent a party thereto, and on the Closing Date, each of the Collateral
Documents (except the Mortgages) and the Collateral Cooperation Agreement, and on such later date as provided in Schedule 5 hereto,
each of the Mortgages, will be duly executed and delivered by the Company and the Guarantors, to the extent a party thereto, and,
when duly executed and delivered in accordance with its terms by each of the other parties thereto, will constitute a valid and
legally binding agreement of the Company and the Guarantors, to the extent a party thereto, enforceable against the Company and
the Guarantors, to the extent a party thereto, in accordance with its terms, subject to the Enforceability Exceptions.

 

(q)         Collateral
Documents, Financing Statements and Collateral.

 

(i)           Upon
execution and delivery, the Mortgages will be effective to grant a legal, valid and enforceable mortgage lien or security title
and security interest on all of the mortgagor’s right, title and interest in the applicable real property listed on Schedule
4 hereto (each, a “Mortgaged Property” and, collectively, the “Mortgaged Properties”). When the Mortgages,
together with fixture filings to the extent such fixture filings are required in any applicable jurisdiction to perfect a security
interest in any fixtures described

 

    8

     

    

 

 in such Mortgages that constitute real property, are duly recorded in the proper recorders’
offices or appropriate public records and the mortgage recording fees and taxes in respect thereof are paid and compliance is otherwise
had with the formal requirements of state law, applicable to the recording of real estate mortgages generally, each such Mortgage
(together with any such fixture filing with respect to the fixtures described therein) shall constitute a validly perfected and
enforceable first-priority lien or security title and security interest in the related Mortgaged Property constituting real property
Collateral for the benefit of the Trustee and the holders of the Securities, subject only to Permitted Liens (as defined below)
and any state of facts which a survey, inspection or title search of the Mortgaged Properties would disclose that do not, and would
not reasonably be expected to, materially detract from the value of any of the Mortgaged Properties or materially interfere with
the use thereof (the “Permitted Exceptions”), and to the Enforceability Exceptions;

 

(ii)          Upon
execution and delivery, the Collateral Agreement and each of the Intellectual Property Security Agreements will be effective to
grant a legal, valid and enforceable security interest in all of the grantor’s right, title and interest in the Collateral
(other than the Mortgaged Properties), subject to the Enforceability Exceptions;

 

(iii)          Upon
due and timely filing and/or recording of the financing statements (including, without limitation, financing statements covering
any equipment and fixtures described in the Mortgages) and Intellectual Property Security Agreements, as applicable, with respect
to the Collateral described in the Collateral Agreement, the Intellectual Property Security Agreements and the equipment and fixtures
described in the Mortgages that constitute personal property (the “Personal Property Collateral”), the security interests
granted thereby will constitute valid, perfected first-priority liens and security interests in the Personal Property Collateral,
to the extent such security interests can be perfected by the filing and/or recording, as applicable, of financing statements, Intellectual
Property Security Agreements and Mortgages for the benefit of the Trustee and the holders of the Securities, and such security
interests will be enforceable in accordance with the terms contained therein against all creditors of any grantor or mortgagor
and subject only to liens expressly permitted to be incurred or exist on the Collateral under the Indenture (the “Permitted
Liens”), to the Permitted Exceptions and the Enforceability Exceptions; and

 

(iv)         The
Company and its subsidiaries collectively own, have rights in or have the power and authority to collaterally assign rights in
the Collateral, free and clear of any liens other than the Permitted Exceptions and the Permitted Liens.

 

(r)          No
Violation or Default. Neither the Company, the Guarantors nor any of the Designated Subsidiaries is (i) in violation of
its respective charter or by-laws or other organizational documents, (ii) in default, and no event has occurred that, with
notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or
condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company,
the Guarantors or any Designated Subsidiary of the Company is a party or by which the Company, the Guarantors or any Designated
Subsidiary of the Company is bound or to which any property, right or asset of the Company, the Guarantors or any Designated Subsidiary
of the Company is subject or (iii) in violation of any law or statute 

 

    9

     

    

 

or any judgment, order, rule or regulation of any
court or arbitrator or governmental or regulatory authority, except for such defaults and violations in the case of these clauses
(ii) and (iii) that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(s)         Title
to Real and Personal Property. Except as disclosed in the Time of Sale Information and the Offering Memorandum, the Company
and its subsidiaries have good and marketable title to all real properties and good and indefeasible title to all real and other
properties and other assets owned by them that are material to the business of the Company and its subsidiaries, in each case free
from liens, encumbrances, claims, security interests, defects and imperfections of title, except (i) in the case of any real
or personal property constituting Collateral, Permitted Liens and Permitted Exceptions and (ii) in all other cases, (x) such
liens, encumbrances, claims, defects and imperfections of title that would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect and (y) except as disclosed in the Time of Sale Information and the Offering Memorandum,
the Company and its subsidiaries hold their respective leased real or personal property under valid and enforceable leases free
from any liens, encumbrances, claims, security interests, restrictions, defects and imperfections of title or exceptions that would
materially interfere with the business of the Company and its subsidiaries, taken as a whole. The Company and its subsidiaries
own or lease all properties and assets necessary to conduct their business as described in the Time of Sale Information and the
Offering Memorandum.

 

(t)          Licenses
and Permits. The Company and the Designated Subsidiaries possess adequate licenses, certificates, authorities or permits issued
by the appropriate governmental agencies or bodies currently required to conduct their business as described in the Time of Sale
Information and the Offering Memorandum and have not received any notice of proceedings relating to the revocation or adverse modification
of any such license, certificate, authority or permit, except for any failure to possess or any notice of proceedings that, if
determined adversely to the Company or any Designated Subsidiary, would, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.

 

(u)          Descriptions
of the Transaction Documents. Each Transaction Document conforms in all material respects to the description thereof contained
in each of the Time of Sale Information and the Offering Memorandum. The Collateral conforms in all material respects to the description
thereof contained in each of the Time of Sale Information and the Offering Memorandum.

 

(v)         No
Labor Disputes. Except as disclosed in the Time of Sale Information and the Offering Memorandum, no labor dispute with
the employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company or the Guarantors, is imminent
that would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.

 

(w)         Title
to Intellectual Property. Except as would not reasonably be expected to have a Material Adverse Effect, (i) the Company
and the Designated Subsidiaries own, possess, have the right to use or can acquire on reasonable terms adequate patents, patent
applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names and other
source indicators, copyrights and copyrightable works, know-how, trade secrets, systems, procedures, proprietary or confidential
information and all other intellectual

 

    10

     

    

 

 property, industrial property and proprietary rights (collectively, “Intellectual
Property”) to conduct their respective businesses; (ii) the Company and the Designated Subsidiaries’ conduct of
their respective businesses does not infringe, misappropriate or otherwise violate any Intellectual Property of any person; (iii) the
Company and the Designated Subsidiaries have not received any written notice of any claim relating to Intellectual Property; and
(iv) to the knowledge of the Company and the Guarantors, the Intellectual Property of the Company and the Designated Subsidiaries
is not being infringed, misappropriated or otherwise violated by any person.

 

(x)          Compliance
With Environmental Laws. Except as disclosed in the Time of Sale Information and the Offering Memorandum, neither the Company
nor any of its subsidiaries is in violation of any statute, any rule, regulation, decision or order of any governmental agency
or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating
to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “environmental
laws”), owns or operates any real property contaminated with any hazardous or toxic substance that is subject to any environmental
laws, is liable for any off-site disposal or contamination pursuant to any environmental laws, or is subject to any pending claim
relating to any environmental laws, which violation, contamination, liability or claim would reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect; and the Company and the Guarantors are not aware of any pending investigation
which would reasonably be expected to lead to such a claim.

 

(y)          Legal
Proceedings. Except as described in the Time of Sale Information and the Offering Memorandum, there are no legal, governmental
or regulatory actions, claims, suits, arbitrations or proceedings (“Actions”) pending to which the Company or any of
its subsidiaries is a party or to which any property, right or asset of the Company or any of its subsidiaries is the subject that
could, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and neither any such Actions
nor any legal, governmental or regulatory investigations to which the Company or any of its subsidiaries is a party or to which
any property, right or asset of the Company or any of its subsidiaries is the subject that could, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, are, to the knowledge of the Company and the Guarantors, threatened by
any governmental or regulatory authority or by others.

 

(z)          Financial
Statements of the Company. The financial statements of the Company and the related notes thereto included or incorporated by
reference in the Time of Sale Information and the Offering Memorandum present fairly in all material respects the consolidated
financial position of the Company and its consolidated subsidiaries as of the dates shown and their results of operations and cash
flows for the periods shown, and, except as otherwise disclosed in the Time of Sale Information and the Offering Memorandum, such
financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”)
applied on a consistent basis throughout the periods covered thereby, and the supporting schedules included or incorporated by
reference in the Time of Sale Information and the Offering Memorandum present fairly the information required to be stated therein;
and the other financial information of the Company included or incorporated by reference in the Time of Sale Information and the
Offering Memorandum has been derived from the accounting records of the Company and its subsidiaries and presents fairly in all
material respects the information shown thereby.

 

    11

     

    

 

(aa)        Taxes.
The Company and its Designated Subsidiaries have timely filed all material federal, state, local and foreign tax returns that have
been required to be filed and have paid all material taxes indicated by said returns and all assessments related to material taxes
received by any of them to the extent that such material taxes have become due and are not being contested in good faith in appropriate
proceedings. All material tax liabilities have been adequately provided for in the financial statements of the Company.

 

(bb)       No
Material Adverse Change. Since the date of the most recent financial statements of the Company included or incorporated by
reference in the Time of Sale Information and the Offering Memorandum, (i) there has not been any material change in the capital
stock or long term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside
for payment, paid or made by the Company on any class of capital stock (other than any regular quarterly dividend), or any material
adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, rights,
assets, management, financial position, results of operations or prospects of the Company and its subsidiaries taken as a whole;
(ii) neither the Company nor any of its subsidiaries has entered into any transaction or agreement that is material to the
Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to
the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained
any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance,
or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory
authority, except in each case of (i), (ii) and (iii) of this Section 3(bb) as otherwise disclosed in the Time of
Sale Information and the Offering Memorandum.

 

(cc)        Reporting
Requirements. The Company is subject to the reporting requirements of either Section 13 or Section 15(d) of
the Exchange Act and files reports with the Commission on the Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system.

 

(dd)       Independent
Accountants. PricewaterhouseCoopers LLP, who has certified certain financial statements of the Company and its subsidiaries,
are independent public accountants with respect to the Company and its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.

 

(ee)       No
Undisclosed Relationships. No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries,
on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of its subsidiaries,
on the other, that would be required by the Securities Act to be described in a registration statement to be filed with the Commission
and that is not so described in the each of Time of Sale Information and the Offering Memorandum.

 

(ff)         Compliance
With ERISA. (1) Each employee benefit plan (including, without limitation, any “multiemployer plan” within
the meaning of Section 4001(a)(3) of ERISA (a “Multiemployer Plan”), within the meaning of Section 3(3) of
the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that is maintained, administered or contributed
to by the Company or any of its ERISA Affiliates for employees or former employees of the 

 

    12

     

    

 

Company
and its ERISA Affiliates has been maintained in compliance in all material respects with its terms and the requirements of any
applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986,
as amended (the “Code”); (2) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975
of the Code, has occurred with respect to any such plan excluding transactions effected pursuant to a statutory or administrative
exemption and transactions that have been corrected in accordance with Internal Revenue Service and Department of Labor guidance;
(3) no failure to meet the minimum funding standards under Section 412 of the Code or Section 302 of ERISA has
occurred with respect to any such plan which is subject to Section 412 of the Code or Section 302 of ERISA and no application
has been made for a waiver or modification of the minimum funding standard (including any required installment payments) under
Section 412 of the Code or Section 302 of ERISA with respect to any such plan; (4) except as otherwise disclosed
in the Time of Sale Information and the Offering Memorandum, the fair market value of the assets of each such plan, other than
a Multiemployer Plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits
accrued under such plan based on actuarial assumptions and methods that are compliant with the requirements of Code Section 430(h) and
regulations thereunder; (5) neither the Company nor any of its ERISA Affiliates has completely or partially withdrawn from
any Multiemployer Plan (within the meaning of Section 4203 or Section 4205 of ERISA) and, none of the Company or its
ERISA Affiliates reasonably expects to incur any material liability with respect to the complete or partial withdrawal from one
or more Multiemployer Plans and (6) and neither the Company nor any of its affiliates has incurred, or reasonably expects
to incur, any liability under Title IV of ERISA in respect of any such plan (including any Multiemployer Plan), other than liability
for the payment of required PBGC insurance premiums under Section 4007 of ERISA; provided, that for purposes of clauses
(1) – (3), such representations shall be made to the knowledge of the Company and the Guarantors.

 

As used herein, “ERISA Affiliate”
means any trade or business (whether or not incorporated) that, together with the Company or any of its subsidiaries, is treated
as a single employer under Section 414(b) or (c) of the Internal Revenue Code or is under common control with the
Company or any of its subsidiaries under Section 4001 of ERISA or, solely for purposes of Section 302 of ERISA and Section 412
of the Internal Revenue Code, is treated as a single employer under Section 414 of the Internal Revenue Code.

 

(gg)       Disclosure
Controls. The Company and its subsidiaries maintain an effective system of “disclosure controls and procedures”
(as defined in Rule 13a-15(e) of the Exchange Act) that is designed to ensure that information required to be disclosed
by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within
the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure
that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions
regarding required disclosure. As of the date of the Time of Sale Information and the Offering Memorandum, the Company and its
subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15
of the Exchange Act.

 

(hh)       Accounting
Controls. The Company and its subsidiaries maintain systems of “internal control over financial reporting” (as
defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed
by, or under the

 

    13

     

    

 

supervision of their
respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with GAAP, including, but not limited to internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
(iii) access to assets is permitted only in accordance with management’s general or specific authorization, (iv) the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences and (v) the interactive data in eXtensible Business Reporting Language included or incorporated
by reference in each of the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum is prepared
in accordance with the Commission’s rules and guidelines applicable thereto. There are no “material weaknesses”
in the Company’s internal controls over financial reporting.

 

(ii)          Sarbanes-Oxley
Act. There is and has been no failure on the part of the Company or to the Company’s knowledge, any of the Company’s
directors or officers, in their capacities as such, to comply in all material respects with the applicable provisions of the Sarbanes-Oxley
Act of 2002, as amended, and the rules and regulations promulgated in connection therewith, including Section 402 related
to loans and Sections 302 and 906 related to certifications.

 

(jj)          No
Unlawful Payments. Except as specifically disclosed in the Company’s prior public filings, neither the Company nor any
of its subsidiaries, nor any director, officer or employee of the Company or any of its subsidiaries nor, to the knowledge of
the Company and the Guarantors, any agent or affiliate acting on behalf of the Company or any of its subsidiaries, each in their
capacity as such, has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense
relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct
or indirect unlawful payment or unlawful benefit to any foreign or domestic government official or employee, including of any
government-owned or controlled entity or of a public international organization, or any person acting in an official capacity
for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated
or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery
or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or
other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper
payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce policies and procedures designed to
promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.

 

(kk)       Compliance
with Anti-Money Laundering Laws. The operations of the Company and its subsidiaries are and have been conducted at all times
in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and
Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the
Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money Laundering
Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority

 

    14

     

    

 

 or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge
of the Company or the Guarantors, threatened.

 

(ll)         Compliance
with Sanctions Laws. Neither the Company nor any of its subsidiaries, directors, officers nor, to the knowledge of the Company
or the Guarantors, employees, agents or affiliates or any other person associated with or acting on behalf of the Company or any
of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government (including,
without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S.
Department of State and including, without limitation, the designation as a “specially designated national” or “blocked
person”), the United Nations Security Council (“UNSC”), the European Union or other relevant sanctions authority
(collectively, “Sanctions”), nor is the Company or any of its subsidiaries or the Guarantors organized or resident
in a country or territory that is the subject or target of Sanctions (including, Cuba, Iran, North Korea, Syria and Crimea
(each, a “Sanctioned Country”)); and the Company will not directly or indirectly use the proceeds of the offering
of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner
or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such
funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business
in any Sanctioned Country, or (iii) in any other manner that will result in a violation by any person (including any person
participating in the transaction, whether as initial purchaser, underwriter, advisor, investor or otherwise) of Sanctions. For
the past five years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any unlawful
dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of
Sanctions or with any Sanctioned Country.

 

(mm)      No
Stabilization. Neither the Company nor the Guarantors has taken, directly or indirectly, any action designed to or that could
reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities.

 

(nn)       Investment
Company Act. Neither the Company nor the Guarantors is and, after giving effect to the offering and sale of the Securities
and the application of the proceeds thereof, as described in the Time of Sale Information and the Offering Memorandum, none of
them will be, an “investment company” as defined in the Investment Company Act of 1940, as amended.

 

(oo)        Statistical
and Market Data. Nothing has come to the attention of the Company that has caused the Company to believe that the statistical
and market-related data included or incorporated by reference in the Time of Sale Information and the Offering Memorandum is not
based on or derived from sources that are reliable and accurate in all material respects.

 

(pp)       Forward-Looking
Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act) included or incorporated by reference in the Time of Sale Information or the Offering Memorandum has been
made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.

 

(qq)       Stock
Options. With respect to the stock options (the “Stock Options”) granted pursuant to the stock-based compensation
plans of the Company and its subsidiaries (the 

 

    15

     

    

 

“Company Stock
Plans”), (i) each Stock Option intended to qualify as an “incentive stock option” under Section 422
of the Code so qualifies, (ii) each grant of a Stock Option was duly authorized no later than the date on which the grant
of such Stock Option was by its terms to be effective (the “Grant Date”) by all necessary corporate action, including,
as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and
any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such
grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in accordance with the
terms of the Company Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including
the rules of the New York Stock Exchange and any other exchange on which Company securities are traded and (iv) each
such grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes) of the
Company and disclosed in the Company’s filings with the Commission in accordance with the Exchange Act and all other applicable
laws. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company of granting, Stock
Options prior to, or otherwise coordinating the grant of Stock Options with, the release or other public announcement of material
information regarding the Company or its subsidiaries or their results of operations or prospects.

 

(rr)         eXtensible
Business Reporting Language. The interactive data in eXtensible Business Reporting Language included or incorporated by reference
in the Time of Sale Information and the Offering Memorandum fairly presents the information called for in all material respects
and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto.

 

(ss)       Cybersecurity;
Data Protection. The Company and its subsidiaries’ information technology assets and equipment, computers, systems,
networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for,
and operate and perform in all material respects as required in connection with the operation of the business of the Company and
its subsidiaries as currently conducted. The Company and its subsidiaries have implemented and maintained commercially reasonable
controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity,
continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive,
confidential or regulated data (“Personal Data”)) used in connection with their businesses, and, to the knowledge
of the Company and the Guarantors, there have been no breaches, violations, outages or unauthorized uses of or accesses to same,
except for those would not reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are presently
in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court
or arbitrator or governmental or regulatory authority and contractual obligations relating to the privacy and security of IT Systems
and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or
modification.

 

(tt)         Rule 144A
Eligibility. On the Closing Date, the Securities will not be of the same class as securities listed on a national securities
exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation system; and each
of the Time of Sale Information, as of the Time of Sale, and the Offering Memorandum, as of its date, contains or will contain
all the information that, if requested by a prospective purchaser of the Securities,

 

    16

     

    

 

 would be required to be provided to such
prospective purchaser pursuant to Rule 144A(d)(4) under the Securities Act.

 

(uu)       No
Integration. Neither the Company nor any of its affiliates (as defined in Rule 501(b) of Regulation D) has, directly
or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined
in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that would require registration
of the Securities under the Securities Act.

 

(vv)       No
General Solicitation. None of the Company or any of its affiliates or any other person acting on its or their behalf (other
than the Initial Purchasers, as to which no representation is made) has (i) solicited offers for, or offered or sold, the
Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of
Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act
or (ii) engaged in any directed selling efforts within the meaning of Regulation S under the Securities Act (“Regulation
S”), and all such persons have complied with the offering restrictions requirement of Regulation S.

 

(ww)      Securities
Law Exemptions. Assuming the accuracy of the representations and warranties of the Initial Purchasers contained in Section 2(b) (including
Annex C hereto) and their compliance with their agreements set forth therein, it is not necessary, in connection with the issuance
and sale of the Securities to the Initial Purchasers and the offer, resale and delivery of the Securities by the Initial Purchasers
in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, to register the Securities
under the Securities Act or to qualify the Indenture under the Trust Indenture Act of 1939, as amended.

 

(xx)        No
Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement
or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution
on such subsidiary’s capital stock or similar ownership interest, from repaying to the Company any loans or advances to
such subsidiary from the Company or from transferring any of such subsidiary’s properties or assets to the Company or any
other subsidiary of the Company, except for any such restrictions (a) as described in each of the Time of Sale Information
and the Offering Memorandum or (b) that will be permitted by the Indenture.

 

(yy)       Solvency.
Immediately after the consummation of the offering of the Securities and the Concurrent Offerings (as such term is defined in
the Time of Sale Information and the Offering Memorandum), the Company and the Guarantors, when taken together (the “Consolidated
Entity”), will be Solvent. As used in this paragraph, the term “Solvent” means, with respect to a particular
date, that on such date (i) the present fair market value (or present fair saleable value) of the assets of the Consolidated
Entity (which, for purposes of this representation, are assumed to be equal to or exceed the carrying value of such assets) are
not less than the total amount required to pay the probable liabilities of the Consolidated Entity on its total existing debts
and liabilities (including contingent liabilities) as they become absolute and matured, (ii) the Consolidated Entity is able
to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and
become due in the normal course of business, (iii) the Consolidated Entity is not incurring debts or liabilities beyond its
ability to pay as such debts and liabilities mature, (iv) the Consolidated

 

    17

     

    

 

 Entity is not engaged in, or about to engage in,
any business or transaction, and is not about to engage in any business or transaction, for which its property would constitute
unreasonably small capital after giving due consideration to the prevailing practice in the industry in which the Company is engaged
and (v) neither the Company nor any Guarantor is a defendant in any civil action that would result in a judgment that the
Company or such Guarantor is or would become unable to satisfy. In computing the amount of such contingent liabilities at any
time, it is intended that such liabilities will be computed at the amount that, in the light of all the facts and circumstances
existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability.

 

4.            Further
Agreements of the Company and the Guarantors. The Company and the Guarantors jointly and severally covenant and agree with
each Initial Purchaser that:

 

(a)         Delivery
of Copies. The Company will deliver to the Initial Purchasers as many copies of the Preliminary Offering Memorandum, any other
Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including all amendments and supplements
thereto) as the Representative may reasonably request.

 

(b)         Offering
Memorandum, Amendments or Supplements. Before finalizing the Offering Memorandum or making or distributing any amendment or
supplement to any of the Time of Sale Information or the Offering Memorandum or filing with the Commission any document that will
be incorporated by reference therein, the Company will furnish to the Representative and counsel for the Initial Purchasers a copy
of the proposed Offering Memorandum or such amendment or supplement or document to be incorporated by reference therein for review,
and will not distribute any such proposed Offering Memorandum, amendment or supplement or file any such document with the Commission
to which the Representative reasonably objects.

 

(c)          Additional
Written Communications. Before making, preparing, using, authorizing, approving or referring to any Issuer Written Communication,
the Company and the Guarantors will furnish to the Representative and counsel for the Initial Purchasers a copy of such written
communication for review and will not make, prepare, use, authorize, approve or refer to any such written communication to which
the Representative reasonably objects.

 

(d)         Notice
to the Representative. The Company will advise the Representative promptly, and confirm such advice in writing, (i) of
the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time of Sale
Information, any Issuer Written Communication or the Offering Memorandum or the initiation or, to the knowledge of the Company
and the Guarantors, threatening of any proceeding for that purpose; (ii) of the occurrence or, to the knowledge of the Company
and the Guarantors, development of any event at any time prior to the completion of the initial offering of the Securities as a
result of which any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum as then amended
or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances existing when such Time of Sale Information, Issuer Written Communication
or the Offering Memorandum is delivered to a purchaser, not misleading; and (iii) of the receipt by the Company of any notice
with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation,
or to the knowledge of the Company, threatening of any proceeding for such purpose; and the Company will use its commercially

 

    18

     

    

 

 reasonable
efforts to prevent the issuance of any such order preventing or suspending the use of any of the Time of Sale Information, any
Issuer Written Communication the Offering Memorandum or suspending any such qualification of the Securities and, if any such order
is issued, will obtain as soon as possible the withdrawal thereof.

 

(e)         Ongoing
Compliance of the Offering Memorandum and Time of Sale Information. (1) If at any time prior to the completion of the
initial offering of the Securities (i) any event or, to the knowledge of the Company and the Guarantors, development shall
occur or condition shall exist as a result of which the Offering Memorandum as then amended or supplemented would include any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light
of the circumstances existing when the Offering Memorandum is delivered to a purchaser, not misleading or (ii) it is necessary
to amend or supplement the Offering Memorandum to comply with applicable law, the Company will immediately notify the Initial Purchasers
thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements
to the Offering Memorandum (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary
so that the statements in the Offering Memorandum as so amended or supplemented (or including such document to be incorporated
by reference therein) will not, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser,
be misleading or so that the Offering Memorandum will comply with applicable law and (2) if at any time prior to the Closing
Date (i) any event or, to the knowledge of the Company and the Guarantors, development shall occur or condition shall exist
as a result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading or (ii) it is necessary to amend or supplement any of the Time of Sale Information
to comply with applicable law, the Company will promptly notify the Initial Purchasers thereof and forthwith prepare and, subject
to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to any of the Time of Sale Information
(or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements
in any of the Time of Sale Information as so amended or supplemented will not, in light of the circumstances under which they were
made, be misleading.

 

(f)          Blue
Sky Compliance. The Company will qualify the Securities for offer and sale under the securities or Blue Sky laws of such U.S.
jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required
for offering and resale of the Securities; provided that neither the Company nor the Guarantors shall be required to (i) qualify
as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be
required to so qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject
itself to taxation in any such jurisdiction if it is not otherwise so subject.

 

(g)         Clear
Market. During the period from the date hereof through and including the date that is 30 days after the date hereof, the Company
and the Guarantors will not, without the prior written consent of the Representative, offer, sell, contract to sell or otherwise
dispose of any debt securities issued or guaranteed by the Company or the Guarantors and having a tenor of more 

 

    19

     

    

 

than one year (other
than the Securities and any municipal bonds, including environmental revenue bonds, issued by or on behalf of the Company).

 

(h)         Use
of Proceeds. The Company will apply the net proceeds from the sale of the Securities as described in each of the Time of Sale
Information and the Offering Memorandum under the heading “Use of proceeds.”

 

(i)           No
Stabilization. The Company will not take, directly or indirectly, any action designed to or that could reasonably be expected
to cause or result in any stabilization or manipulation of the price of the Securities.

 

(j)           Supplying
Information. While the Securities remain outstanding and are “restricted securities” within the meaning of Rule 144(a)(3) under
the Securities Act, the Company and the Guarantors will, during any period in which the Company is not subject to and in compliance
with Section 13 or 15(d) of the Exchange Act, furnish to holders of the Securities, prospective purchasers of the Securities
designated by such holders and securities analysts, in each case upon request, the information required to be delivered pursuant
to Rule 144A(d)(4) under the Securities Act.

 

(k)          DTC.
The Company will assist the Initial Purchasers in arranging for the Securities to be eligible for clearance and settlement
through DTC.

 

(l)           No
Resales by the Company. The Company will not, and will not permit any of its affiliates (as defined in Rule 144 under
the Securities Act) to, resell any of the Securities that have been acquired by any of them, except for Securities purchased by
the Company or any of its affiliates and resold in a transaction registered under the Securities Act.

 

(m)         No
Integration. Neither the Company nor any of its affiliates (as defined in Rule 501(b) of Regulation D) will, directly
or through any agent, sell, offer for sale, solicit offers to buy or otherwise negotiate in respect of, any security (as defined
in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that would require registration
of the Securities under the Securities Act.

 

(n)         No
General Solicitation or Directed Selling Efforts. None of the Company or any of its affiliates or any other person acting on
its or their behalf (other than the Initial Purchasers, as to which no covenant is given) will (i) solicit offers for, or
offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of
Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act
or (ii) engage in any directed selling efforts within the meaning of Regulation S, and all such persons will comply with the
offering restrictions requirement of Regulation S.

 

(o)         Perfection
of Security Interests; Secured Intercompany Loan. The Company and the Guarantors (i) shall complete on or prior to the
Closing Date all filings and other similar actions required in connection with the perfection of security interests in the Collateral
as and to the extent contemplated by the Indenture and the Collateral Documents and (ii) shall take all actions necessary
to maintain such security interests and to perfect security interests in any Collateral acquired after the Closing Date, in each
case as and to the extent contemplated by the Indenture and the Collateral Documents; provided that the Company and the
Guarantors may deliver, furnish

 

    20

     

    

 

and/or cause to be
furnished all of the obligations set forth on Schedule 5 hereto within the time periods set forth therein; provided further,
that the Company and the Guarantors will not be required to deliver the certificates evidencing the capital stock that is required
by the Indenture and the Collateral Documents to be pledged as part of the Collateral until the date which is 60 days following
the Closing Date. For the avoidance of doubt, subsection (i) hereof includes the obligation of the Company and the applicable
Guarantors to, on or prior to the Closing Date, take the following actions with respect to the security interests made in favor
of USS Portfolio Delaware, Inc. pursuant to that certain Revolving Credit Agreement, dated March 1, 2016 that was subsequently
amended and restated by the Amended and Restated Revolving Credit Agreement, dated as of April 25, 2017 (as amended, the
 “Secured Intercompany Loan”): (A) have delivered for filing to the applicable governmental or regulatory authority
the appropriate UCC-3 termination statements and executed intellectual property agreement terminations related to such security
interests and (B) with respect to any mortgages covering real property securing indebtedness under the Secured Intercompany
Loan, have mortgage releases executed by the applicable parties. In addition, (i) no later than 30 days following the Closing
Date or as soon as practicable thereafter using commercially reasonable efforts, the Company and the applicable Guarantors will
provide the Representative with customary evidence, or other evidence in form and substance reasonably satisfactory to the Representative,
that releases or terminations of all of the mortgages (if any) and fixture filings covering real property and fixtures, as the
case may be, securing indebtedness under the Secured Intercompany Loan shall have been filed in the applicable public filing offices
and (ii) no later than 15 days following the Closing Date or as soon as practicable thereafter using commercially reasonable
efforts, the Company and the applicable Guarantors will provide the Representative with customary evidence, or other evidence
in form and substance reasonably satisfactory to the Representative, that all publicly filed financing statements and intellectual
property security agreements in respect of other collateral securing indebtedness under the Secured Intercompany Loan shall have
been filed in the applicable public filing offices.

 

(p)         Mortgage
Opinions. Concurrently with the delivery of the Mortgages, the Company and the Guarantors shall cause local counsel for the
Company in the state of each Mortgaged Property, to furnish to the Representative, at the request of the Company, its written opinion,
addressed to the Initial Purchasers, with respect to the enforceability of such Mortgages and other related matters customarily
included in such opinions, in each case in form and substance reasonably satisfactory to the Representative.

 

5.           Certain
Agreements of the Initial Purchasers. Each Initial Purchaser hereby represents and agrees that it has not and will not use,
authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an offer to sell
or the solicitation of an offer to buy the Securities other than (i) the Preliminary Offering Memorandum and the Offering
Memorandum, (ii) a written communication that contains no “issuer information” (as defined in Rule 433(h)(2) under
the Securities Act) that was not included (including through incorporation by reference) in the Time of Sale Information or the
Offering Memorandum, (iii) any written communication listed on Annex A or prepared pursuant to Section 4(c) above
(including any electronic road show), (iv) any written communication prepared by such Initial Purchaser and approved by the
Company in advance in writing or (v) any written communication relating to or that contains the terms of the Securities and/or
other information that was included

 

    21

     

    

 

 (including through incorporation by reference) in the Time of Sale Information or the Offering
Memorandum.

 

6.           Conditions
of Initial Purchasers’ Obligations. The obligation of each Initial Purchaser to purchase the Securities on the Closing
Date as provided herein is subject to the performance by the Company and the Guarantors of their respective covenants and other
obligations hereunder and to the following additional conditions:

 

(a)          DTC.
The Securities shall be eligible for clearance and settlement through the DTC.

 

(b)         Representations
and Warranties. The representations and warranties of the Company and the Guarantors contained herein shall be true and correct
on the date hereof and on and as of the Closing Date; and the statements of the Company, the Guarantors and their respective officers
made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date.

 

(c)          No
Downgrade. Subsequent to the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement,
(i) no downgrading shall have occurred in the rating accorded any securities issued or guaranteed by the Company or any of
its subsidiaries by any “nationally recognized statistical rating organization,” as such term is defined under Section 3(a)(62)
under the Exchange Act and (ii) no such organization shall have publicly announced that it has under surveillance or review,
or has changed its outlook with respect to, its rating of any securities issued or guaranteed by the Company or any of its subsidiaries
(other than an announcement with positive implications of a possible upgrading).

 

(d)         No
Material Adverse Change. Subsequent to the execution and delivery of this Agreement, no event or condition of a type described
in Section 3(bb) hereof shall have occurred or shall exist, which event or condition is not described in the Time of Sale
Information (excluding any amendment or supplement thereto) and the Offering Memorandum (excluding any amendment or supplement
thereto) and the effect of which in the judgment of the Representative makes it impracticable or inadvisable to proceed with the
offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information
and the Offering Memorandum.

 

(e)         Officer’s
Certificate. The Representative shall have received on and as of the Closing Date, a certificate of an executive officer of
each of the Company and the Guarantors (in each case, acting solely in such capacity on behalf of the Company and the Guarantors,
as applicable, and not in such executive officer’s personal capacity), who has specific knowledge of the Company’s
or the Guarantor’s financial matters and is reasonably satisfactory to the Representative (i) confirming that such officer
has carefully reviewed the Time of Sale Information and the Offering Memorandum and, to the knowledge of such officer, the representations
set forth in Sections 3(b) and 3(d) hereof are true and correct; (ii) confirming that the other representations
and warranties of the Company and the Guarantors in this Agreement are true and correct and that the Company and the Guarantors
have complied with all agreements and satisfied all conditions on their part to be performed or satisfied hereunder at or prior
to the Closing Date; and (iii) to the effect set forth in paragraphs (b), (c) and (d) of this Section 6.

 

    22

     

    

 

(f)          Comfort
Letters for the Company. On the date of this Agreement and on the Closing Date, PricewaterhouseCoopers LLP shall have furnished
to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to
the Initial Purchasers, in form and substance reasonably satisfactory to the Representative, containing statements and information
of the type customarily included in accountants’ “comfort letters” to initial purchasers with respect to the
Company’s financial statements and certain financial information contained or incorporated by reference in each of the Time
of Sale Information and the Offering Memorandum; provided that the letter delivered on the Closing Date shall use a “cut-off”
date no more than three business days prior to the Closing Date.

 

(g)         Opinion
and Negative Assurance Statement of Counsel for the Company and the Guarantors. Milbank LLP, counsel for the Company and the
Guarantors, shall have furnished to the Representative, at the request of the Company, an opinion and negative assurance statement,
dated the Closing Date, and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative,
to the effect set forth in Annex D hereto.

 

(h)         Opinion
and Negative Assurance Statement of Counsel for the Initial Purchasers. The Representative shall have received on and as of
the Closing Date, an opinion and negative assurance statement of Simpson Thacher & Bartlett LLP, counsel for the Initial
Purchasers, addressed to the Initial Purchasers, with respect to such matters as the Representative may reasonably request, and
such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such
matters.

 

(i)           No
Legal Impediment to Issuance. No action shall have been taken and no statute, rule, regulation or order shall have been enacted,
adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent
the issuance or sale of the Securities or the issuance of the Guarantees; and no injunction or order of any federal, state or foreign
court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities or the issuance
of the Guarantees.

 

(j)          Good
Standing. The Representative shall have received on and as of the Closing Date, satisfactory evidence of the good standing
of the Company, the Guarantors and each Designated Subsidiaries, other than the Designated Subsidiaries organized and existing
outside the United States, in their respective jurisdictions of organization and their good standing in such other jurisdictions
as the Representative may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate
governmental authorities of such jurisdictions.

 

(k)          Indenture
and Securities. The Indenture shall have been duly executed and delivered by a duly authorized officer of the Company, the
Guarantors, the Trustee and the Collateral Agent, and the Securities shall have been duly executed and delivered by a duly authorized
officer of the Company and duly authenticated by the Trustee.

 

(l)          Lien
Searches. The Representative shall have received the results of a recent lien search in each of the jurisdictions of organization
of the Company and the Guarantors and any other jurisdictions in which valid filings with respect to the Company and the Guarantors
may be in effect, and such search shall reveal no liens on any of the assets of the Company and the Guarantors or their respective
subsidiaries except for Permitted Exceptions or Permitted Liens.

 

    23

     

    

 

(m)         Collateral
Agreement and Intellectual Property Security Agreements. The Initial Purchasers shall have received conformed counterparts
of the Collateral Agreement and each of the Intellectual Property Security Agreements that shall have been executed and delivered
by duly authorized officers of each party thereto, in form and substance reasonably satisfactory to the Representative.

 

(n)         Collateral
Cooperation Agreement. The Initial Purchasers shall have received conformed counterparts of the Collateral Cooperation Agreement
that shall have been executed and delivered by duly authorized officers of each party thereto, in form and substance reasonably
satisfactory to the Representative.

 

(o)         Filings,
Registration and Recordings. Except as otherwise contemplated by the Intellectual Property Security Agreements and the Collateral
Agreement, each document (including any Uniform Commercial Code financing statement) required by the Intellectual Property Security
Agreements and the Collateral Agreement, or under law or reasonably requested by the Representative, in each case, to be filed,
registered or recorded, or delivered for filing on or prior to the Closing Date, including filings in the U.S. Patent and Trademark
Office and the U.S. Copyright Office in order to create in favor of the Trustee, for the benefit of the holders of the Securities,
a perfected first-priority lien and security interest in the Personal Property Collateral that can be perfected by the making of
such filings, registrations or recordations, prior and superior to the right of any other person (other than Permitted Liens),
shall be executed and in proper form for filing, registration or recordation.

 

(p)          Pledged
Notes. On the Closing Date, the Trustee or the Collateral Agent shall have received each promissory note owed to the Company
or the Guarantors endorsed (without recourse) in blank (or accompanied by an executed transfer form in blank) by the pledgor thereof,
as set forth in Schedule 6 hereto.

 

(q)         Secured
Intercompany Loan. On or prior to the Closing Date, the Company and the applicable Guarantors shall have provided the Representative
with evidence, in form and substance reasonably satisfactory to the Representative, that (A) the appropriate UCC-3 termination
statements and executed intellectual property agreement terminations relating to the security interests securing indebtedness under
the Secured Intercompany Loan have been delivered to the applicable governmental or regulatory authority for filing and (B) with
respect to any mortgages covering real property securing indebtedness under the Secured Intercompany Loan, mortgage releases have
been executed by the applicable parties.

 

(r)          CFO
Certificate. The Representative shall have received, on the date of this Agreement and on the Closing Date, a letter dated
the date thereof, in a form and substance reasonably satisfactory to the Representative, from Christine S. Breves, Senior Vice
President and Chief Financial Officer of the Company.

 

(s)          Additional
Documents. On or prior to the Closing Date, the Company and the Guarantors shall have furnished to the Representative such
further certificates and documents as the Representative may reasonably request.

 

    24

     

    

 

All opinions, letters, certificates and
evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if
they are in form and substance reasonably satisfactory to counsel for the Initial Purchasers.

 

7.            Indemnification
and Contribution.

 

(a)          Indemnification
of the Initial Purchasers. The Company and the Guarantors jointly and severally agree to indemnify and hold harmless each Initial
Purchaser, its affiliates, directors and officers and each person, if any, who controls such Initial Purchaser within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages
and liabilities (including, without limitation, reasonable, documented legal fees and other reasonable, documented expenses incurred
in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several,
that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Preliminary
Offering Memorandum, any of the other Time of Sale Information, any Issuer Written Communication, any road show as defined in Rule 433(h) under
the Securities Act (a “road show”) or the Offering Memorandum (or any amendment or supplement thereto) or any omission
or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out
of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity
with any information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the
Representative expressly for use therein, it being understood and agreed that the only such information furnished by any Initial
Purchaser consists of the information described as such in subsection (b) of this Section 7.

 

(b)         Indemnification
of the Company and the Guarantors. Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless
the Company and the Guarantors, and each of their respective directors, its officers and each person, if any, who controls the
Company or the Guarantors within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to
the same extent as the indemnity set forth in paragraph (a) of this Section 7, but only with respect to any losses, claims,
damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission
made in reliance upon and in conformity with any information relating to such Initial Purchaser furnished to the Company in writing
by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, any of the other
Time of Sale Information (including any of the other Time of Sale Information that has subsequently been amended), any Issuer Written
Communication, any road show or the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed
that the only such information furnished by any Initial Purchaser consists of the information set forth in the fifth paragraph,
the fourth and fifth sentences of the ninth paragraph and the eleventh paragraph under the under the heading “Plan of Distribution”
in the Preliminary Offering Memorandum and the Offering Memorandum.

 

(c)          Notice
and Procedures. If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall
be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or
(b) of this Section 7, such person (the “Indemnified Person”) shall promptly notify the person 

 

    25

     

    

 

against whom such
indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the
Indemnifying Person shall not relieve it from any liability that it may have under paragraph (a) or (b) of this Section 7
except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such
failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) of this Section 7.
If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying
Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not,
without the written consent of the Indemnified Person, be counsel to the Indemnifying Person, such consent not to be unreasonably
withheld, conditioned or delayed) to represent the Indemnified Person and any others entitled to indemnification pursuant to this
Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the reasonable, documented fees and
expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the
right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person
unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying
Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the
Indemnified Person shall have reasonably concluded that there are or are likely to be legal defenses available to it that are
different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding
(including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and the Indemnified Person shall
have reasonably concluded that representation of both parties by the same counsel would be inappropriate due to actual or potential
differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding
or related proceeding in the same jurisdiction, be liable for the reasonable, documented fees and expenses of more than one separate
firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as
they are incurred. Any such separate firm for any Initial Purchaser, its affiliates, directors and officers and any control persons
of such Initial Purchaser shall be designated in writing by J.P. Morgan Securities LLC and any such separate firm for the Company,
the Guarantors, their respective directors and officers and any control persons of the Company and the Guarantors shall be designated
in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its
written consent, but if settled with such consent or if there be a final judgment for the plaintiff by a court of competent jurisdiction,
the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement
or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying
Person reimburse the Indemnified Person for reasonable, documented fees and expenses of counsel as contemplated by this paragraph,
the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such
settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying
Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement.
No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened
proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought
hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such

 

    26

     

    

 

 Indemnified Person,
in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter
of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act
by or on behalf of any Indemnified Person.

 

(d)         Contribution.
If the indemnification provided for in paragraph (a) or (b) of this Section 7 is unavailable to an Indemnified Person
or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under
such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such
Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to
reflect the relative benefits received by the Company and the Guarantors on the one hand and the Initial Purchasers on the other
from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable
law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also
the relative fault of the Company and the Guarantors on the one hand and the Initial Purchasers on the other in connection with
the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations. The relative benefits received by the Company and the Guarantors on the one hand and the Initial Purchasers on
the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by
the Company from the sale of the Securities and the total discounts and commissions received by the Initial Purchasers in connection
therewith, as provided in this Agreement, bear to the aggregate offering price of the Securities. The relative fault of the Company
and the Guarantors on the one hand and the Initial Purchasers on the other shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or the Guarantors or by the Initial Purchasers and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.

 

(e)          Limitation
on Liability. The Company, the Guarantors and the Initial Purchasers agree that it would not be just and equitable if contribution
pursuant to this Section 7 were determined by pro rata allocation (even if the Initial Purchasers were treated as one
entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred
to in paragraph (d) of this Section 7. The amount paid or payable by an Indemnified Person as a result of the losses,
claims, damages and liabilities referred to in paragraph (d) of this Section 7 shall be deemed to include, subject to
the foregoing limitations, any reasonable, documented legal or other expenses reasonably incurred by such Indemnified Person in
connection with any such action or claim. Notwithstanding the provisions of this Section 7, in no event shall an Initial Purchaser
be required to contribute any amount in excess of the amount by which the total discounts and commissions received by such Initial
Purchaser with respect to the offering of the Securities exceeds the amount of any damages that such Initial Purchaser has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’ obligations to contribute
pursuant to this Section 7 are several in proportion to their respective purchase obligations hereunder and not joint.

 

    27

     

    

 

(f)          Non-Exclusive
Remedies. The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or remedies that
may otherwise be available to any Indemnified Person at law or in equity.

 

8.            Effectiveness
of this Agreement. This Agreement shall become effective as of the date first written above.

 

9.           Termination.
This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Company, if after the execution
and delivery of this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially
limited on or by any of the New York Stock Exchange, the NASDAQ Stock Market or the over-the-counter market; (ii) trading
of any securities issued or guaranteed by the Company or the Guarantors shall have been suspended on any exchange or in any over-the-counter
market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State
authorities or a material disruption in commercial banking or securities settlement or clearance services in the United States
shall have occurred; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial
markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is
material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities
on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum.

 

10.          Defaulting
Initial Purchaser. (a) If, on the Closing Date, any Initial Purchaser defaults on its obligation to purchase the Securities
that it has agreed to purchase hereunder, the non-defaulting Initial Purchasers may in their discretion arrange for the purchase
of such Securities by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after
any such default by any Initial Purchaser, the non-defaulting Initial Purchasers do not arrange for the purchase of such Securities,
then the Company shall be entitled to a further period of 36 hours within which to procure other persons reasonably satisfactory
to the non-defaulting Initial Purchasers to purchase such Securities on such terms. If other persons become obligated or agree
to purchase the Securities of a defaulting Initial Purchaser, either the non-defaulting Initial Purchasers or the Company may postpone
the Closing Date, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company
or counsel for the Initial Purchasers may be necessary in the Time of Sale Information, the Offering Memorandum or in any other
document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Time of Sale Information
or the Offering Memorandum that effects any such changes. As used in this Agreement, the term “Initial Purchaser” includes,
for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant
to this Section 10, purchases Securities that a defaulting Initial Purchaser agreed but failed to purchase.

 

(a)          If,
after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial Purchasers
by the non-defaulting Initial Purchasers and the Company as provided in paragraph (a) of this Section 10, the aggregate
principal amount of such Securities that remains unpurchased does not exceed one-eleventh of the aggregate principal amount of
all the Securities, then the Company shall have the right to require each non-defaulting Initial Purchaser to purchase the principal
amount of Securities that such Initial Purchaser agreed 

 

    28

     

    

 

to purchase hereunder plus such Initial Purchaser’s pro rata share
(based on the principal amount of Securities that such Initial Purchaser agreed to purchase hereunder) of the Securities of such
defaulting Initial Purchaser or Initial Purchasers for which such arrangements have not been made.

 

(b)         If,
after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial Purchasers
by the non-defaulting Initial Purchasers and the Company as provided in paragraph (a) of this Section 10, the aggregate
principal amount of such Securities that remains unpurchased exceeds one-eleventh of the aggregate principal amount of all the
Securities or if the Company shall not exercise the right described in paragraph (b) of this Section 10, then this Agreement
shall terminate without liability on the part of the non-defaulting Initial Purchasers. Any termination of this Agreement pursuant
to this Section 10 shall be without liability on the part of the Company or the Guarantors, except that the Company and the
Guarantors will continue to be liable for the payment of expenses as set forth in Section 10 hereof and except that the provisions
of Section 7 hereof shall not terminate and shall remain in effect.

 

(c)          Nothing
contained herein shall relieve a defaulting Initial Purchaser of any liability it may have to the Company, the Guarantors or any
non-defaulting Initial Purchaser for damages caused by its default.

 

11.          Payment
of Expenses. (a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement
is terminated, the Company and the Guarantors jointly and severally agree to pay or cause to be paid all costs and expenses incident
to the performance of their respective obligations hereunder, including without limitation, (i) the costs incident to the
authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii) the
costs incident to the preparation and printing of the Preliminary Drafts, the Preliminary Offering Memorandum, any other Time of
Sale Information, any Issuer Written Communication and the Offering Memorandum (including any amendment or supplement thereto)
and the distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the
documented, reasonable fees and expenses of the Company’s and the Guarantors’ counsel and independent accountants;
(v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for
investment of the Securities under the laws of such jurisdictions as the Representative may designate and the preparation, printing
and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Initial Purchasers); (vi) any
fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of the Trustee, the Collateral Agent
and any paying agent (including related fees and expenses of any counsel to such parties); (viii) all expenses and application
fees incurred in connection with the approval of the Securities for book-entry transfer by DTC; (ix) the fees and expenses
incurred with respect to creating, documenting and perfecting the security interests in the Collateral as contemplated by the Collateral
Documents (including the reasonable and documented related fees and expenses of one outside counsel to the Initial Purchasers and
one local counsel to the Initial Purchasers for each applicable jurisdiction for all periods prior to and after the Closing Date
in connection with such actions); and (x) all expenses incurred by the Company in connection with any “road show”
presentation to potential investors.

 

(a)          If
(i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any reason fails to tender the Securities
for delivery to the Initial Purchasers or (iii) the Initial Purchasers decline to purchase the Securities for any reason permitted
under this Agreement, other

 

    29

     

    

 

 than due to a termination pursuant to Section 10, the Company and the Guarantors jointly and severally
agree to reimburse the Initial Purchasers for all reasonable, documented out-of-pocket costs and expenses (including the fees and
expenses of their counsel) incurred by the Initial Purchasers in connection with this Agreement and the offering contemplated hereby.

 

12.          Persons
Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each
Initial Purchaser referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any
other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.
No purchaser of Securities from any Initial Purchaser shall be deemed to be a successor merely by reason of such purchase.

 

13.          Survival.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company, the Guarantors and
the Initial Purchasers contained in this Agreement or made by or on behalf of the Company, the Guarantors or the Initial Purchasers
pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Securities
and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf
of the Company, the Guarantors or the Initial Purchasers.

 

14.         Certain
Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided, the term “affiliate”
has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day
other than a day on which banks are permitted or required to be closed in New York City; (c) the term “subsidiary”
has the meaning set forth in Rule 405 under the Securities Act; and (d) the term “significant subsidiary”
has the meaning set forth in Rule 1-02 of Regulation S-X under the Exchange Act.

 

15.          Patriot
Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26,
2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective clients,
including the Company, which information may include the name and address of their respective clients, as well as other information
that will allow the Initial Purchasers to properly identify their respective clients.

 

16.         Miscellaneous.
(a) Authority of the Representative. Any action by the Representative or Initial Purchasers hereunder may be taken
by J.P. Morgan Securities LLC and on behalf of the Initial Purchasers, and any such action taken by J.P. Morgan Securities LLC
shall be binding upon the Initial Purchasers.

 

(a)         Notices.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given upon receipt at
the addresses set forth in the following sentence. Notices to the Initial Purchasers shall be given to the Representative at c/o
J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: 212-834-6081); Attention: High Yield Syndicate.
Notices to the Company and the Guarantors shall be given to it at 600 Grant Street, Room 1500 and Room 6100, Pittsburgh, PA 15219-2800
(e-mail: mwfurry@uss.com and ASJahn@uss.com), Attention:
Mark Furry, Associate General Counsel - Corporate, and Arne Jahn, Vice President – Treasurer and Chief Risk Officer.

 

    30

     

    

 

(b)         Governing
Law. This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by,
and construed in accordance with, the laws of the State of New York.

 

(c)         Submission
to Jurisdiction. Each party hereto hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts
in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. Each party hereto waives any objection which it may now or hereafter have to the laying of venue
of any such suit or proceeding in such courts. Each party hereto agrees that final judgment in any such suit, action or proceeding
brought in such court shall be conclusive and binding upon it and may be enforced in any court to the jurisdiction of which it
is subject by a suit upon such judgment.

 

(d)         Waiver
of Jury Trial. Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of
or relating to this Agreement.

 

(e)         Counterparts.
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication),
each of which shall be an original and all of which together shall constitute one and the same instrument. The words “execution,”
 “signed,” “signature,” “delivery,” and words of like import in or relating to this Agreement
or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or
the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually
executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties
hereto consent to conduct the transactions contemplated hereunder by electronic means.

 

(f)          Amendments
or Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom,
shall in any event be effective unless the same shall be in writing and signed by the parties hereto.

 

(g)         Headings.
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning
or interpretation of, this Agreement.

 

(h)         Recognition
of the U.S. Special Resolution Regimes. (A) In the event that any Initial Purchaser that is a Covered Entity becomes subject
to a proceeding under a U.S. Special Resolution Regime, the transfer from such Initial Purchaser of this Agreement, and any interest
and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S.
Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States
or a state of the United States.

 

(B)            In
the event that any Initial Purchaser that is a Covered Entity or a BHC Act Affiliate of such Initial Purchaser becomes subject
to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such
Initial Purchaser are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special 

 

    31

     

    

 

Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.

 

As used in this Section 16(i):

 

“BHC Act Affiliate”
has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. §
1841(k).

 

“Covered Entity”
means any of the following:

 

(i)            a
 “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);

 

(ii)            a
 “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or

 

(iii)           a
 “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).

 

“Default Right” has
the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1,
as applicable.

 

“U.S. Special Resolution
Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title
II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.

 

    32

     

    

 

If the foregoing is
in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.

 

	 	Very truly yours,
	 	 
	 	UNITED STATES STEEL CORPORATION
	 	 
	 	 
	 	By: 	/s/ Christine Breves
	 	 	Name: Christine Breves 
	 	 	Title: Senior Vice President and Chief Financial Officer

 

	 	USS PORTFOLIO DELAWARE, INC.
	 	 
	 	 
	 	By: 	/s/ Arne Jahn
	 	 	Name: Arne Jahn 
	 	 	Title: Treasurer

 

	 	U.S. STEEL SEAMLESS TUBULAR OPERATIONS, LLC
	 	 
	 	 
	 	By: 	/s/ Arne Jahn
	 	 	Name: Arne Jahn 
	 	 	Title: Treasurer

 

	 	U.S. STEEL OILWELL SERVICES,
LLC
	 	 
	 	 
	 	By: 	/s/ Arne Jahn
	 	 	Name: Arne Jahn 
	 	 	Title: Treasurer

 

	 	U.S. STEEL TUBULAR PRODUCTS, INC.
	 	 
	 	 
	 	By: 	/s/ Arne Jahn
	 	 	Name: Arne Jahn 
	 	 	Title: Treasurer

 

[Signature
page to Purchase Agreement for Senior Secured Notes]

 

    33

     

    

 

	 	UNITED STATES STEEL INTERNATIONAL, INC.
	 	 
	 	 
	 	By: 	/s/ Arne Jahn
	 	 	Name: Arne Jahn 
	 	 	Title: Treasurer

 

	 	U.S. STEEL HOLDCO LLC
	 	 
	 	 
	 	By: 	/s/ Arne Jahn
	 	 	Name: Arne Jahn 
	 	 	Title: Treasurer

 

	Confirmed and accepted as of the date set forth on the first page hereof	 
	 	 
	J.P. Morgan securities llc	 
	 	 
	By	/s/
    Chris Lingenfelter	 
	 	 
	 	Authorized Signatory	 
	 	 
	For itself and on behalf of the several Initial Purchasers listed in Schedule 1 hereto.	 

 

    34

     

    

 

Schedule 1

 

[Intentionally omitted.]

 

    Sch. 1 - 1

     

    

 

Schedule 2

 

Guarantors

 

		·	USS Portfolio Delaware, Inc.

		·	U.S. Steel Seamless Tubular Operations, LLC

		·	U.S. Steel Oilwell Services, LLC

		·	U.S. Steel Tubular Products, Inc.

		·	United States Steel International, Inc.

		·	U. S. Steel Holdco LLC

 

    Sch. 2 - 1

     

    

 

Schedule 3

 

Designated Subsidiaries of the Company

 

	
        Entity
	 	
        Jurisdiction of Organization

	U.S. Steel Tubular Products, Inc.	 	Delaware
	USS Portfolio Delaware, Inc.	 	Delaware
	U. S. Steel Košice, s.r.o	 	Slovak Republic
	U.S. Steel Oilwell Services, LLC	 	Delaware
	U. S. Steel Seamless Tubular Operations, LLC	 	Texas
	United States Steel International, Inc.	 	New Jersey
	USS Galvanizing, Inc.	 	Delaware
	Grant Assurance Corporation	 	Vermont
	U.S. Steel Holdings, Inc.	 	Delaware
	U. S. Steel Holdco LLC	 	Delaware
	
        Pitcal, Inc.

        USS UPI Holdco, LLC
	 	
        Delaware

        Delaware

	USS-Posco Industries	 	California 

 

    Sch. 3 - 1

     

    

 

Schedule 4

 

Real Property

 

	

Property	Grantor	Record Owner	County Recorder’s Office for Mortgage Filing
	
        Great Lakes Works

         

        (Approximately 900 acres)
	United States Steel Corporation	
        United States Steel Corporation

         
	
        Wayne County, Michigan

        Wayne County Register of Deeds

        400 Monroe Street,

        7th Floor

        Detroit, MI 48226

        (313) 224-5850

         

	
         

         

	
        Gary Works

         

        (Approximately 3,000 acres)
	United States Steel Corporation	United States Steel Corporation	
        Lake County, Indiana

        Lake County Recorder’s Office

        Building “A”, 2nd Floor

        2293 North Main Street

        Crown Point, IN 46307

        (219) 755-3730

         

	
        Excluding the Midwest Plant and East Chicago Tin

         

	
        Granite City Works

         

        (Approximately 1,000 acres)
	United States Steel Corporation	United States Steel Corporation	
        Madison County, Illinois

        Madison County Recorder’s Office

        157 North Main Street, Suite 211

        P.O. Box 308

        Edwardsville, IL 62025

        (618) 296-4475

         

	
         

         

	
        Edgar Thompson Plant

         

        (Approximately 175 acres)
	United States Steel Corporation	United States Steel Corporation	
        Allegheny County, Pennsylvania

        Allegheny County Department of Real Estate

        County Office Building

        542 Forbes Avenue, Room 101

        Pittsburgh, PA 15219

        (412) 350-4226

         

	
         

         

 

    Sch. 4 - 1

     

    

 

	

Property	Grantor	Record Owner	County Recorder’s Office for Mortgage Filing
	
        Irvin Plant

         

        (Approximately 500 acres)
	United States Steel Corporation	United States Steel Corporation	
        Allegheny County, Pennsylvania

        Allegheny County Department of Real Estate

        County Office Building

        542 Forbes Avenue, Room 101

        Pittsburgh, PA 15219

        (412) 350-4226

         

	
         

         

	
        Clairton Plant

         

        (Approximately 400 acres)

        

        
	United States Steel Corporation	United States Steel Corporation	
        Allegheny County, Pennsylvania

        Allegheny County Department of Real Estate

        County Office Building

        542 Forbes Avenue, Room 101

        Pittsburgh, PA 15219

        (412) 350-4226

         

	
         

         

	
        Lorain Tubular Plant

         

        (Approximately 290 acres)
	
        United States Steel Corporation (as to the land)

         

        U. S. Steel Seamless Tubular Operations, LLC (as to the improvements
        and fixtures)
	
        United States Steel Corporation (as to the land)

         

        U. S. Steel Seamless Tubular Operations, LLC (as to the improvements
        and fixtures)
	
        Lorain County, Ohio

        Lorain County Recorder of Deeds,

        226 Middle Avenue,

        Elyria, Ohio 44035

        (440) 329-5148

         

	Ground Lease, dated March 1, 2016, between United States Steel Corporation, as lessor, and U.S. Steel Seamless Tubular Operations, LLC, as lessee

 

    S-2

     

    

 

Schedule 5

 

Mortgage-Related Requirements

 

With respect to the fee
interest in each Mortgaged Property on the Closing Date that forms a part of the Collateral and the fee interest in any real property
acquired by the Company or any Guarantor after the Closing Date that forms a part of the Collateral, within 180 days of the Closing
Date or 45 days of the date of acquisition, as applicable:

 

		1.	the Company or such Guarantor (as applicable) shall deliver to the Collateral Agent, as mortgagee
or beneficiary, as applicable, for the ratable benefit of itself and the Holders, fully executed counterparts of Mortgages, in
accordance with the requirements of the Indenture and/or the Collateral Documents, duly executed by the Company or such Guarantor
(as applicable), together with satisfactory evidence of the completion (or satisfactory arrangements for the completion) of all
recordings and filings of such Mortgage (and payment of any taxes or fees in connection therewith), together with any necessary
fixture filings, as may be necessary to create a valid, perfected Lien, with the priority required by the Indenture, the Collateral
Documents and the Intercreditor Agreement, as applicable, subject only to Permitted Liens, against the properties purported to
be covered thereby; and

 

		2.	the Company or the applicable Guarantor shall deliver to the Collateral Agent such filings, local
counsel opinions as to, among other customary opinions, the enforceability of the subject Mortgage, opinions of counsel in the
jurisdiction of organization of the owner of the applicable Mortgaged Property covering the due authorization, execution and delivery
of the applicable Mortgage, flood hazard determinations and evidence of any required flood insurance (to the extent such flood
determinations and insurance are required by applicable laws), along with such other documents, instruments, certificates and agreements,
and any other documents necessary to comply with clause (1) above and to perfect the Collateral Agent’s security interest,
with the Lien priority required by the Indenture, the Collateral Documents and the Intercreditor Agreement, as applicable, and
as the Collateral Agent and its counsel may otherwise reasonably request.

 

    Sch. 5 - 1

     

    

 

Schedule 6

 

Promissory Notes

 

None

 

    Sch. 6 - 1

     

    

 

Annex A

 

Time of Sale Information

 

		·	Pricing Term Sheet, dated May 21, 2020, relating to the Securities and attached as Annex B hereto.

 

    Annex A - 1

     

    

 

Annex B

 

Pricing Term Sheet

 

[Intentionally omitted.]

 

    Annex B - 1

     

    

 

Annex C

 

Restrictions on Offers and Sales Outside
the United States

 

In connection with
offers and sales of Securities outside the United States:

 

(a)          Each
Initial Purchaser acknowledges that the Securities have not been registered under the Securities Act and may not be offered or
sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in
transactions not subject to, the registration requirements of the Securities Act.

 

(b)          Each
Initial Purchaser, severally and not jointly, represents, warrants and agrees that:

 

(i)           Such
Initial Purchaser has offered and sold the Securities, and will offer and sell the Securities, (A) as part of their distribution
at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the
Closing Date, only in accordance with Regulation S under the Securities Act (“Regulation S”) or Rule 144A
or any other available exemption from registration under the Securities Act.

 

(ii)          None
of such Initial Purchaser or any of its affiliates or any other person acting on its or their behalf has engaged or will engage
in any directed selling efforts with respect to the Securities, and all such persons have complied and will comply with the offering
restrictions requirement of Regulation S.

 

(iii)         At
or prior to the confirmation of sale of any Securities sold in reliance on Regulation S, such Initial Purchaser will have sent
to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities
from it during the distribution compliance period a confirmation or notice to substantially the following effect:

 

The Securities covered hereby have
not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be
offered or sold within the United States or to, or for the account or benefit of, U.S. persons (i) as part of their distribution
at any time or (ii) otherwise until 40 days after the later of the commencement of the offering of the Securities and the
date of original issuance of the Securities, except in accordance with Regulation S or Rule 144A or any other available exemption
from registration under the Securities Act. Terms used above have the meanings given to them by Regulation S.

 

(iv)         Such
Initial Purchaser has not and will not enter into any contractual arrangement with any distributor with respect to the distribution
of the Securities, except with its affiliates or with the prior written consent of the Company.

 

    Annex C - 1

     

    

 

 

Terms used in paragraph (a) and this
paragraph (b) and not otherwise defined in this Agreement have the meanings given to them by Regulation S.

 

(c)          Each
Initial Purchaser acknowledges that no action has been or will be taken by the Company that would permit a public offering of the
Securities, or possession or distribution of any of the Time of Sale Information, the Offering Memorandum, any Issuer Written Communication
or any other offering or publicity material relating to the Securities, in any country or jurisdiction where action for that purpose
is required.

 

    Annex C - 2

     

    

 

 

Annex D

 

Form of Opinion and Negative
Assurance Statement of Counsel for the Company

 

[Intentionally omitted.]

 

    Annex D - 1Exhibit
4.1

 

NEITHER THIS SECURITY
NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE
UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

china
ceramics co., ltd.

 

Warrant Shares: __________                                                                                                     Initial Exercise Date: November
__, 2020

                                          Issue Date: May __, 2020

 

THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after November __, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on
November __, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from China Ceramics
Co., Ltd., a company formed in the British Virgin Islands (the “Company”), up to ___________ shares (as subject
to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

  

Section 1.     Definitions.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase
Agreement (the “Purchase Agreement”), dated May __, 2020, among the Company and the purchasers signatory thereto.

 

Section 2.     Exercise.

 

a)                  Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or
times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly
executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed
hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of
Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise
as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of
Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure
specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be
required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been
exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3)
Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of
lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of
Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased
and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day
of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by
reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face
hereof.

 

    1

     

    

 

b)                 
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $____, subject to adjustment
hereunder (the “Exercise Price”).

 

c)                 
Cashless Exercise. If at the time of exercise hereof there is no effective registration statement registering, or
the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also
be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = as
applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such
Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or
(2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular
trading hours” (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such
Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the
applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by
Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise
is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter
(including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a
Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of
 “regular trading hours” on such Trading Day;

 

    2

     

    

 

(B) = the
Exercise Price of this Warrant, as adjusted hereunder; and

 

(X) =
the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The Company agrees not to
take any position contrary to this Section 2(c).

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on
a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as
applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock
are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a
share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest
of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the
Company.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg
L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or
OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and
if prices for the Common Stock are then reported in The Pink Open Market (or a similar organization or agency succeeding to
its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.

 

    3

     

    

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).

 

		d)	Mechanics of Exercise.

 

i.            Delivery
of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is
then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the
Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the
Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and
otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the
delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to
the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of
Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided
that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a
Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages
and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on
the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such
Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a
participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
 “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days,
on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the
Notice of Exercise.

 

    4

     

    

 

ii.                    
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at
the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver
to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant.

 

iii.                 
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv.                  Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the
Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the
provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such
date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s
brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant
Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A)
pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the
number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of
the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was
not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common
Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For
example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an
attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon
request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any
other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.

 

    5

     

    

 

v.                 
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such
exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi.                 
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses
shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may
be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it
for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any
Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar
functions) required for same-day electronic delivery of the Warrant Shares.

 

vii.                 
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely
exercise of this Warrant, pursuant to the terms hereof.

 

e)       Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such
Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation
(as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by
the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of
Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for
purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case
subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of
such determination. In addition, a determination as to any group status as contemplated above shall be determined in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this
Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the
Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or
oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of
shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be
determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the
Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock
was reported. The “Beneficial Ownership Limitation” shall be [9.99/4.99% of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of
this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of
the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial
Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The
provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the
terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the
intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to
properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of
this Warrant.

 

    6

     

    

 

Section 3.     Certain
Adjustments.

 

a)                 
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend
or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b)                  Subsequent
Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be
entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no
such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to
participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the
Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in
abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the
Beneficial Ownership Limitation).

 

    7

     

    

 

c)                 
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or
make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other
similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such
case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that,
to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the
Holder exceeding the Beneficial Ownership Limitation).

 

d)                  Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and
all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or
more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of
Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including
any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the
other Persons making or party to, such stock or share purchase agreement or other business combination) (each a
 “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the
right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company,
if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this
Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on
the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in
respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be
received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it
receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the
Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined
below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however,
that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of
Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation
of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes
Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the
Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any
combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of
consideration in connection with the Fundamental Transaction. “Black Scholes Value” means the value of
this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg, L.P.
(“Bloomberg”) determined as of the day of consummation of the applicable Fundamental Transaction for
pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to
the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B)
an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg
(determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of
the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of
(i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being
offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public
announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental
Transaction and (D) a remaining option time equal to the time between the date of the public announcement of the applicable
Fundamental Transaction and the Termination Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will
be made by wire transfer of immediately available funds within five Business Days of the Holder’s election (or, if
later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of
the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of
this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by
the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of
such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into
account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is
reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the
Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead
to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of
the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been
named as the Company herein.

 

 

 

    8

     

    

 

 

e)                  Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

    9

     

    

 

f)                  
Notice to Holder.

 

i.           
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3,
the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.            Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock,
(C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company
(and all of its Subsidiaries, taken as a whole) is a party, any sale or transfer of all or substantially all of the assets of
the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property,
or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the
Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last
facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days
prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to
be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken,
the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the
Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such
notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this
Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.

 

    10

     

    

 

g)                 
Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any
time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price
to any amount and for any period of time deemed appropriate by the board of directors of the Company.

 

Section 4.                    Transfer
of Warrant.

 

a)                 
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant
in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which
the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b)                 
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid
office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)                  Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
 “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any
distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

    11

     

    

 

d)                 
Transfer Restrictions. If,
at the time of the surrender of this Warrant in connection with any transfer of this
Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement
under the Securities Act and under applicable state securities or blue sky laws
or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant
to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.

 

e)                 
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring
this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and
not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act
or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5.                    Miscellaneous.

 

a)                 
No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i),
except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless
exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.

 

b)                 
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to
the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock
certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.

 

c)                 
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of
any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised
on the next succeeding Business Day.

 

    12

     

    

 

d)                  Authorized
Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and
unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of
any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full
authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such
Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be
issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting
the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.

 

e)                 
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant
shall be determined in accordance with the provisions of the Purchase Agreement.

 

    13

     

    

 

f)                  
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not
registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal
securities laws.

 

g)                 
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part
of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without
limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply
with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such
amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees,
including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise
enforcing any of its rights, powers or remedies hereunder.

 

h)                 
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the
Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

i)                  
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise
this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to
any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.

 

j)                  
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of
damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)                 
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced
hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors
and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time
of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)                  
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the
Company and the Holder.

 

m)               Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

n)                 
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

    14

     

    

 

IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	 	china ceramics co.,
        ltd.

	 	By:	 
	 	 	Name:
	 	 	Title:

 

    15

     

    

 

NOTICE OF EXERCISE

 

To:                   china
ceramics co., ltd.

 

(1)  
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.

 

(2)  
Payment shall take the form of (check applicable box):

 

[ ] in lawful
money of the United States; or

 

[ ] if permitted
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c),
to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3)  
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_____________________________________

 

 

The Warrant Shares shall be delivered to
the following DWAC Account Number:

 

_____________________________________

 

_____________________________________

 

_____________________________________

 

(4) Accredited Investor.
The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933,
as amended.

 

[SIGNATURE
OF HOLDER]

 

Name of Investing Entity: ___________________________________________________________________                                                                 _____

Signature of Authorized Signatory of
Investing Entity: ______________________________________________                                                                 ___

Name of Authorized Signatory: _________________________________________________________                                                                 __________

Title of Authorized Signatory: _________________________________________________________                                                                 ___________

Date: ___________________________________________________________________________                                                             _____________

 

    16

     

    

 

EXHIBIT B

 

ASSIGNMENT
FORM

(To assign the foregoing Warrant, execute
this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to

 

	Name:	 
	 	(Please
Print)
	Address:	 
	 	(Please
Print)  
	Phone
Number:	 
	Email
Address: 	 
	 	 
	Dated:
_______________ __, ______	 
	Holder’s
Signature:                                                                          	 
	Holder’s
Address:                                                                          	 

    17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]